Dec 11, 2018 at 12:00 PM EST to Dec 13, 2018 at 11:59 PM EST

Iovance Biotherapeutics, Inc. at Tumor Targeted Lymphocyte Summit 2018

Panel: Strategies to Optimize and Improve Manufacturing Processes in TIL, CTL and Neoantigen Therapies
Presenter: Joseph Wypych, Vice President of Manufacturing
Date: Wednesday, Dec. 12, 2018
Time: 10 a.m. EST

Presentation: Developing Tumor Infiltrating Lymphocytes for the Treatment of Cancer
Presenter: Maria Fardis, Ph.D., MBA, President and Chief Executive Officer
Date: Thursday, Dec. 13, 2018
Time: 9:10 a.m. EST

The Tumor Targeted Lymphocyte Summit is the first, dedicated meeting that unites the expert community working in TIL and CTL therapies to network, learn and determine strategies to enhance the efficacy of adoptive cell therapy in solid tumors. For additional information, please see


United States